ARK Genomic Revolution ETF

ARKGCboe US

$44.55▲ +0.24 (+0.54%)

Pre-market: $44.53

Pre-marketData as of 06:35 AM ET · 15-min delay

Every calculator, already run for ARKG

What is it worth?

P/E calculatorHow does this multiple compare to peers and its own history?Run →DCF calculatorTen years of free cash flow, discounted back to today.Run →Reverse DCFSolves the price backwards for the growth it already requires.Run →EV / EBITDAThe price with debt added and cash netted off.Run →PEG ratioThe multiple divided by the growth meant to justify it.Run →Graham numberGraham's ceiling from earnings and book value.Run →P/S ratioFor companies whose earnings are not the point yet.Run →Intrinsic valueDCF, multiples and Graham run together as one range.Run →

Is it any good?

ROIC calculatorWhether a dollar invested earns more than it costs.Run →Altman Z-scoreFive balance-sheet ratios weighted into a distress score.Run →Piotroski F-scoreNine pass-fail tests on profit, leverage and efficiency.Run →Debt to equityHow much of the balance sheet is borrowed.Run →Interest coverageHow many times operating profit covers the interest bill.Run →Profit marginGross, operating and net, each against the sector.Run →Free cash flowOperating cash after the capex needed to keep going.Run →Rule of 40Revenue growth plus margin, the software health line.

What does it return & pay?

ROE calculatorProfit against the equity shareholders left in.Run →EPS growthEarnings per share compounded over the filings.Run →CAGR calculatorCompound rate on revenue, earnings, cash or price.Run →Dividend yieldWhat it pays, and whether free cash flow covers it.0.00%Net payout yieldDividends plus buybacks, less shares issued.Run →Owner earningsBuffett's version: cash a buyer could actually take out.Run →

You have the numbers on ARKG. Get the argument.

A written report on which of these readings actually decide the outcome for ARK Genomic Revolution ETF, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.

Key market data

Market cap—

P/E (TTM)—

Forward P/E—

Beta—

EPS (TTM)—

Dividend yield—

Volume3.25M

Avg volume3.23M

52-week range

$23.43$44.88

About ARK Genomic Revolution ETF

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.

Compare ARK Genomic Revolution ETF against related stocks

Explore additional stock overview pages and jump directly into full report generation for each symbol.

Nearby tickers

Additional public equities from our tracked universe.

ARHS stock overview ARGO stock overview ARKK stock overview ARES stock overview ARKO stock overview ARE stock overview ARLP stock overview

Market leaders

Large-cap symbols investors frequently compare.

AAPL stock overview MSFT stock overview NVDA stock overview AMZN stock overview GOOGL stock overview META stock overview TSLA stock overview JPM stock overview

Investor Guides For ARK Genomic Revolution ETF

Start with the evergreen guides that matter most for this sector, then move back into the ticker page when you want to pressure-test the framework on a live name.

Investor FoundationsHow to Value a Stock Without Fooling Yourself Investor FoundationsHow to build a DCF that holds under pressure Investor FoundationsDCF sensitivity: make the fragile assumptions visible Investor FoundationsStock multiples: read the argument inside the number

Generate your full ARKG research report

DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on ARK Genomic Revolution ETF, in minutes. 3 free reports included with every account — no credit card required.